Year: 2022

omeprazole 40 MG Injection omeprazole 40 MG Injection is an anti-ulcer medication used to treat conditions in which the stomach produces excessive amounts of acid. High levels of stomach acid can cause stomach and duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. omeprazole 40 MG Injection is used to treat active gastric (stomach) or duodenal (small intestine) ulcers that are causing bleeding or severe erosions. 40 mg omeprazole Injection disrupts the final stage of acid release in the stomach. As a result, acidity in the stomach is reduced, and the ulcer healing process is accelerated. Headache, pain at the injection site, diarrhoea, and dizziness are common omeprazole 40 MG Injection side effects. If you have previously been allergic to this medication, do not use it. 40 mg omeprazole A health care professional in a hospital or clinic will inject medication into your vein. Injection omeprazole is used in patients who have damage to their oesophagus (the tube that transports food from the throat to the stomach) or who are unable to take omeprazole orally. If you have acid-related diseases, you should avoid spicy and fatty foods, and alcohol, and limit caffeinated drinks or beverages such as coffee, tea, and cola. Consume a well-balanced diet. Always try to eat dinner three hours before going to bed. Uses of omeprazole 40 MG Injection omeprazole 40mg Dry Vial Of 1 Powder For Injection injection is used as an alternative to oral medication or when oral medication is ineffective. It is primarily used to treat Zollinger-Ellison syndrome (a disease in which tumours cause the stomach to produce too much acid), but it may also be used to treat stomach and intestinal ulcers, gastroesophageal reflux disease (GERD), (a disorder in which acid frequently flows back into the tube connecting your mouth and stomach, causing heartburn or acid indigestion) when oral medication is not indicated. What is its purpose of it? GORD (Gastroesophageal Reflux Disease)Gastroesophageal Reflux Disease (GERD) is an acid reflux disease that occurs when stomach acid flows back into the oesophagus or food pipe on a regular basis. The main symptoms of GERD are heartburn and acid indigestion. To some extent, this condition can be managed with lifestyle changes and over-the-counter medications. However, sometimes medications or surgery are required to provide relief. omeprazole 40 MG Injection reduces stomach acid production, which aids in the short-term treatment of GERD. Syndrome of Zollinger-EllisonZollinger-Ellison Syndrome is a condition in which tumours form in the pancreas and duodenum (organs located behind the stomach) (the first part of the small intestine). These tumours produce a hormone called gastrin, which causes an increase in stomach acid. 40 mg omeprazole Injection is used to treat an excess of acid produced in the stomach as a result of tumours. Ulcer in the duodenumDuodenal ulcers are open sores that form in the duodenum’s lining (the beginning of the small intestine). After leaving your stomach, food travels directly to the duodenum. It happens when the stomach’s excess acid damages the duodenum’s protective layer. It can also be the result of an infection or irritation. omeprazole 40 MG Injection is used to treat active duodenal ulcers that cause bleeding or severe erosions Gastric ulcerGastric ulcers are sores that form in the stomach lining. The stomach produces acid to aid in digestion as well as to kill germs. The stomach cells form a protective mucus layer to protect themselves from acid damage. This layer is damaged when there is an increase in stomach acid production, which causes an ulcer. It can also be the result of an infection or irritation. omeprazole 40 MG Injection is used to treat active gastric (stomach) ulcers that cause bleeding or severe erosions. Side Effects of omeprazole 40 MG Injection Constipation Diarrhoea and stomach ache Nausea, vomiting Itching and rashes due to allergy Difficulty in breathing Irregular heartbeat Fatigue, tiredness Increased risk of infections, especially on long-term use Sleep disturbance Taste changes Low levels of sodium in the blood (rare) Joint pains (arthralgia) or muscle pains (myalgia) Hair loss (alopecia) (rare) Dosage Missed Dose Because omeprazole 40 MG Injection is administered by a qualified healthcare professional in a hospital or clinical setting, the possibility of a missed dose is extremely low. Overdose Because omeprazole 40 MG Injection is administered by a qualified healthcare professional in a hospital or clinical setting, the chances of an overdose are extremely low. If an overdose is suspected, the doctor will initiate emergency medical treatment. General Instructions omeprazole 40 MG Injection should be administered in a clinic or hospital by a qualified healthcare professional. If you have a known allergy to this medication, tell your doctor. Omeprazole injection is available in a strength of 40 mg. Interactions Interactions Before beginning any medication, consult your doctor about all potential interactions. Alcohol Interactions Description Alcohol interaction is unknown. It is best to consult your doctor before using this product. Instructions Alcohol interaction is unknown. It is best to consult your doctor before using this product. Disease interactions OsteoporosisOsteoporosis is a bone disease that causes bones to weaken and fracture (may break from a fall). omeprazole 40 MG Injection can reduce bone density over time (thinning of bones). Calcium is required for the formation of bones. This medication reduces calcium absorption in the body, resulting in calcium deficiency. This can increase the risk of bone fractures, especially in people who have osteoporosis. To avoid bone thinning, take calcium supplements or increase your calcium intake in your diet. Taking vitamin D supplements along with omeprazole 40 MG Injection can help the body absorb calcium. Liver impairmentOmeprazole is primarily converted to its active form in the liver. As a result, patients with liver disease should exercise caution when using omeprazole 40 MG Injection. Colitis40 mg omeprazole Diarrhea may result from the injection. This medication should be used with extreme caution in patients with gastrointestinal (mouth to anus) diseases, especially colitis (swelling of the inner lining of the colon), as it can cause severe diarrhoea. Salvavidas pharma – Omeprazole 40

Ceftriaxone for injection is a widely used antibiotic given by healthcare professionals to treat serious bacterial infections. This page explains what it is used for, the key safety points, and what hospitals, distributors and importers should check when sourcing ceftriaxone injection from India. Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India. This page is for general information and trade enquiries. It does not replace the approved prescribing information or advice from a doctor or pharmacist. Quick Facts Item Details Product Ceftriaxone for injection (ceftriaxone sodium), powder for solution for injection or infusion Brand Name SALCEF Manufacturer SALVAVIDAS PHARMACEUTICAL Injection Site IV & IM Form Powder Packaging Type Vial Composition Ceftriaxone For Injection USP Country of Origin Made in India What Is Ceftriaxone? Ceftriaxone is an antibiotic from the cephalosporin group. It works by stopping bacteria from building their cell walls, which kills the bacteria or stops them from multiplying. It comes as a sterile powder that is mixed with a suitable liquid just before it is given. Because it is injected, it is used in hospitals and clinics under medical supervision, not for self-treatment. Like all antibiotics, it works only against bacterial infections and does not treat viral illnesses such as colds or flu. What Is Ceftriaxone Injection Used For? According to typical prescribing information, ceftriaxone may be used to treat infections such as: bacterial meningitis pneumonia and other lower respiratory tract infections middle ear infections (otitis media) urinary tract infections bone and joint infections skin and soft tissue infections certain other infections, and prevention of infection before some surgeries, as set out in the label The exact list of approved uses varies by product and country, so always refer to the label approved for your market. How Is It Given? Ceftriaxone is prepared and given by trained healthcare professionals. Key points from typical prescribing information: It can be given into a vein (injection or infusion) or deep into a muscle. The dose depends on the type and severity of infection and on the patient’s age, weight and condition. The prescriber decides the dose. Dose numbers are intentionally not listed on this page. For injection into a muscle, a lidocaine solution is often used to dissolve the powder to reduce pain. Lidocaine solution must never be given into a vein, and patients allergic to lidocaine need a different approach. Calcium-containing liquids, such as Ringer’s solution or Hartmann’s solution, must not be used to dissolve or dilute ceftriaxone, because a precipitate can form. The full course should be completed as prescribed. Antibiotics should only be used when prescribed, to reduce antibiotic resistance. Important Safety Information Prescribing information for ceftriaxone highlights points such as: Allergy: it must not be used in patients with serious allergy to ceftriaxone, other cephalosporins or, depending on the label, other beta-lactam antibiotics. Severe allergic reactions can occur. Newborns and calcium: ceftriaxone must not be given to premature newborns up to a defined corrected age, or to newborns (28 days or younger) who need, or are expected to need, calcium-containing intravenous solutions, because of the risk of ceftriaxone-calcium precipitation in the lungs and kidneys. Antibiotic-associated diarrhoea: severe or persistent diarrhoea, including Clostridioides difficile infection, can occur during or after treatment. Gallbladder and kidneys: ceftriaxone can form deposits in the gallbladder or kidneys in some patients. Blood tests: it can affect blood counts and some laboratory tests, such as urine glucose tests. Liver and kidney disease, pregnancy and breastfeeding: use needs careful medical assessment and follows the approved label. A doctor or pharmacist must decide whether ceftriaxone is suitable for a particular patient. Possible Side Effects Many people have no serious side effects. Common effects listed in labels include pain, redness or swelling at the injection site, diarrhoea or loose stools, rash and changes in blood or liver test results. Rare but serious reactions include severe allergic reactions, severe skin reactions, serious diarrhoea and blood problems. Anyone receiving ceftriaxone who has difficulty breathing, swelling of the face or throat, a severe rash, severe or bloody diarrhoea, or other worrying symptoms should seek medical help immediately. See the approved label for the complete list. What Buyers Should Check When Sourcing Ceftriaxone Injection Sterile antibiotic powders carry strict quality requirements. When you compare suppliers, ask about: Cephalosporin segregation: whether production uses dedicated or fully segregated areas and air handling to prevent cross-contamination with other products. Sterile manufacturing: the filling process, environmental monitoring and sterility assurance. Release testing: sterility, bacterial endotoxins, assay, related substances, water content, particulate matter, and clarity and colour of the reconstituted solution. Stability data: studies that suit your climate zone. Many African markets fall under ICH Zones IVa and IVb. Packaging: vial, stopper and seal quality, labelling that clearly states strength, and any diluent supplied. Batch documentation: Certificate of Analysis for each batch and traceable batch records. Storage and shipping: the labelled storage conditions and transport method. Export Documents and Regulatory Support Regulators in markets such as Nigeria (NAFDAC), Kenya (Pharmacy and Poisons Board) and Ghana (Ghana FDA) have their own registration rules. Depending on the market, buyers typically need: a valid GMP certificate for the manufacturing site a registration dossier in the format the regulator requests Certificates of Analysis for each batch a Certificate of Pharmaceutical Product (CoPP), where applicable labelling and packaging that meet local requirements Learn more about our regulatory services. Why Source from Salvavidas Pharma? WHO-GMP certified pharmaceutical manufacturer in Surat, Gujarat, India Experience supplying export markets, with a focus on Nigeria, Kenya, Ghana and other African countries Range across finished dosage forms and APIs, including generics, oncology and anti-HIV/ARV products Documentation support for registration and tenders See our manufacturing facility, finished formulations and global presence, or download our company profile. How to Order Send your enquiry: strength, pack, quantity and target country. Confirm specifications: pack type, shelf life, labelling and documents required. Receive a quotation: price, MOQ, lead time and payment terms. Review documents and samples: GMP certificate, specification and, where available, sample documents. Place

The pharmaceutical industry in India is one of the largest in the world, supplying affordable medicines to more than 200 markets. It is known as the pharmacy of the world because of its strength in generic medicines, vaccines, active pharmaceutical ingredients (APIs) and contract manufacturing. This guide explains how big the Indian pharmaceutical industry is, what it exports and where, the main challenges it faces, and the opportunities ahead, using recent, sourced data. It also covers what the industry’s growth means for importers and distributors, especially in Africa. Key Facts at a Glance Indicator Figure Source and period Size of the Indian pharma industry About US$60 billion Pharmexcil, April 2026 Projected size by 2030 US$130 billion Pharmexcil, April 2026; Economic Survey 2025-26 Pharma exports, FY2024-25 US$30.47 billion (up 9.4%) Pharmexcil handbook Pharma exports, FY2025-26 Above US$31 billion DGCIS data, reported May 2026 Pharma exports, April-June 2026 (Q1 FY27) US$8.10 billion (up 6.8%) Pharmexcil, August 2026 Global rank by production volume Third Pharmexcil chairman, April 2026 Global rank by export value 11th Economic Survey 2025-26 (PIB summary) Export destinations More than 200 markets Pharmexcil, April 2026 Share of exports to highly regulated markets More than 60% Pharmexcil, April 2026 How Big Is the Indian Pharmaceutical Industry? The Indian pharmaceutical industry is valued at around US$60 billion, according to Pharmexcil (the Pharmaceuticals Export Promotion Council of India), and is projected to reach US$130 billion by 2030. It is worth separating two rankings that are often mixed up. India is generally described as third in the world by volume of pharmaceutical production. By value of exports it ranks lower (11th, as summarised from the Economic Survey 2025-26), because much of what India makes is affordable generic medicine. A Short History Before 1970: foreign companies dominated the Indian market and domestic competition was limited. 1970 onwards: the Indian Patents Act of 1970 recognised process patents rather than product patents for medicines. This helped local companies build skills in reverse-engineering and producing generics, and exports began to grow. 1990s: economic liberalisation encouraged Indian companies to expand abroad and invest in quality and facilities. 2005: an amendment to the Patents Act introduced product patents, in line with international trade rules. Indian companies adapted by strengthening R&D, regulatory skills and partnerships. What India Makes and Exports India’s pharmaceutical output covers several product groups: Generic formulations: tablets, capsules, injectables, syrups and other finished dosage forms APIs and bulk drugs: the active ingredients used to make medicines Vaccines and biologicals Contract and third-party manufacturing for other companies’ brands Formulations and biologicals form the largest part of exports. In FY2024-25 drug formulations and biologicals accounted for about 75% of exports (US$22.93 billion) and bulk drugs for US$4.87 billion. In FY2025-26 formulations and biologicals contributed US$23.08 billion, about 74.2% of the total, and vaccines were the fastest-growing category at about US$1.5 billion, up 26.4%. Where Does India Export? The United States is India’s largest single market, accounting for about 31% of exports in April-June 2026. North America, Europe, Africa and Latin America together account for nearly 75% of exports. Export growth has not been smooth. In March 2026 exports fell about 23% from the previous March, which industry leaders linked to US stockpiling ahead of tariffs. Even so, FY2025-26 exports crossed US$31 billion, and growth continued in Q1 FY27. India and Africa Africa is a major and growing destination for Indian medicines. In FY2024-25 it accounted for about 12.9% of India’s pharmaceutical exports, and exports to Africa rose about 13% in FY2025-26. For African importers, the strengths of Indian suppliers include a wide product range, competitive pricing and manufacturers with WHO-GMP certification. Registration is handled country by country, by regulators such as NAFDAC in Nigeria, the Pharmacy and Poisons Board in Kenya and the Ghana FDA. Buyers should check that a supplier can provide a valid GMP certificate, batch Certificates of Analysis and the dossier format their regulator requires. Key Challenges Facing the Industry Price pressure. Domestic price controls and global competition on generics keep margins tight. Trade and tariff volatility. The March 2026 export decline shows how sensitive exports can be to US tariffs and inventory cycles. Dependence on imported inputs. Many manufacturers rely on imported APIs and key starting materials for some products. Quality and regulatory compliance. Meeting GMP standards across many markets requires continuous investment in quality systems. Rising compliance and sustainability costs. Environmental rules, data integrity requirements and audits add cost and complexity. Innovation gap. The industry is strongest in generics, and moving into complex generics, biosimilars and new drugs needs higher R&D spending. Key Opportunities A growing home market. Rising incomes, insurance coverage and healthcare infrastructure support demand, with the industry projected to reach US$130 billion by 2030. Vaccines and biologicals. These were the fastest-growing export categories in FY2025-26. Africa and other emerging markets. Exports to Africa, Oceania and Latin America grew faster than the overall total in FY2025-26. Trade agreements. The government highlights the India-UK CETA, the India-EU FTA and the EFTA agreement as opening new access for pharmaceutical exports. Contract and third-party manufacturing. Global and regional brands increasingly outsource manufacturing to qualified Indian plants. Policy support. Government programmes support domestic manufacturing of bulk drugs and medical products. Leading Indian Pharma Companies India’s pharmaceutical sector includes large listed companies and thousands of small and mid-sized manufacturers. Well-known names include Sun Pharma, Cipla, Dr. Reddy’s, Lupin, Zydus, Aurobindo Pharma, Divi’s Laboratories and Glenmark. Rankings change every year with revenue and market capitalisation, so check a current source before comparing companies. What This Means for Importers and Distributors If you plan to source medicines from India, look beyond price. Check: a valid manufacturing licence and WHO-GMP certificate the dosage forms and therapy areas the plant is approved for quality control, stability data and batch documentation regulatory support for your country’s registration process minimum order quantity, lead time and payment terms For a deeper look, read our guides to choosing a pharma contract manufacturer in India and third-party pharma manufacturing in India. About Salvavidas Pharma Salvavidas Pharma